Oruka Therapeutics (ORKA) to Release Earnings on Thursday

Oruka Therapeutics (NASDAQ:ORKA) is expected to post its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect Oruka Therapeutics to post earnings of ($0.68) per share for the quarter.

Oruka Therapeutics Stock Performance

Shares of NASDAQ:ORKA opened at $11.02 on Friday. The firm has a market cap of $385.70 million, a PE ratio of -1.76 and a beta of 0.77. The stock’s fifty day simple moving average is $15.62. Oruka Therapeutics has a 1-year low of $10.61 and a 1-year high of $53.88.

Analyst Upgrades and Downgrades

A number of brokerages have commented on ORKA. Wedbush restated an “outperform” rating and set a $40.00 price objective on shares of Oruka Therapeutics in a research report on Tuesday, November 19th. Wolfe Research began coverage on shares of Oruka Therapeutics in a research report on Tuesday, February 4th. They set an “outperform” rating and a $20.00 price objective for the company. Finally, HC Wainwright restated a “buy” rating and set a $45.00 price objective on shares of Oruka Therapeutics in a research report on Friday, February 7th. Seven research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $39.86.

Oruka Therapeutics Company Profile

Oruka Therapeutics, Inc is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.